-
Anderson S L, Carton J M, Lou J, et al. 1999. Interferon-induced guanylate binding protein-1 (GBP-1) mediates an antiviral effect against vesicular stomatitis virus and encephalomyocarditis virus. Virology, 256 (1): 8-14.
doi: 10.1006/viro.1999.9614
-
Bourne H R, Sanders D A, McCormick F. 1990. The GTPase superfamily: a conserved switch for diverse cell functions. Nature, 348 (6297): 125-132.
doi: 10.1038/348125a0
-
Bourne H R, Sanders D A, McCormick F. 1991. The GTPase superfamily: conserved structure and molecular mechanism. Nature, 349 (6305): 117-127.
doi: 10.1038/349117a0
-
Cheng Y S, Becker-Manley M F, Chow T P, et al. 1985. Affinity purification of an interferon-induced human guanylate-binding protein and its characterization. J Biol Chem, 260 (29): 15834-15839.
-
Cheng Y S, Patterson C E, Staeheli P. 1991. Interferon-induced guanylate-binding proteins lack an N (T)KXD consensus motif and bind GMP in addition to GDP and GTP. Mol Cell Biol, 11 (9): 4717-4725.
doi: 10.1128/MCB.11.9.4717
-
Frese M, Kochs G, Feldmann H, et al. 1996. Inhibition of bunyaviruses, phleboviruses, and hantaviruses by human MxA protein. J Virol Methods, 70 (2): 915-923.
-
Ghosh A, Praefcke G J, Renault L, et al. 2006. How guanylate-binding proteins achieve assembly-stimulated processive cleavage of GTP to GMP. Nature, 440 (7080): 101-104.
doi: 10.1038/nature04510
-
Guidotti L G, Morris A, Mendez H, et al. 2002. Interferon-regulated pathways that control hepatitis B virus replicationin transgenic mice. J Virol, 76: 2617-2621
doi: 10.1128/JVI.76.6.2617-2621.2002
-
Kunzelmann S, Praefcke G J, Herrmann C. 2005. Nucleotide binding and self-stimulated GTPase activity of human guanylate-binding protein 1 (hGBP1). Methods Enzymol, 404: 512-527.
doi: 10.1016/S0076-6879(05)04045-0
-
Lu Y P, Wang B J, Dong J H, et al. 2007. Construction and Characterization of a Hepatitis B Virus Replicon. Virologica Sinica, 22 (1): 8-13.
doi: 10.1007/s12250-007-0055-7
-
Lubeseder-Martellato C, Guenzi E, Jorg A, et al. 2002. Guanylate-binding protein-1 expression is selectively induced by inflammatory cytokines and is an activation marker of endothelial cells during inflammatory diseases. Am J Pathol, 161 (5): 1749-1751.
doi: 10.1016/S0002-9440(10)64452-5
-
Marschall M, Zach A, Hechtfischer A, et al. 2000. Inhibition of influenza C viruses by human MxA protein. Virus Res, 67 (2): 179-188.
doi: 10.1016/S0168-1702(00)00140-4
-
Modiano N, Lu Y E, Cresswell P. 2005. Golgi targeting of human guanylate-binding protein-1 requires nucleotide binding, isoprenylation, and an IFN-gamma-inducible cofactor. Proc Natl Acad Sci USA, 102 (24): 8680-8685.
doi: 10.1073/pnas.0503227102
-
Naschberger E, Bauer M, Sturzl M. 2005. Human guanylate binding protein-1 (hGBP-1) characterizes and establishes a non-angiogenic endothelial cell activation phenotype in inflammatory diseases.Adv Enzyme Regul, 45: 215-227.
doi: 10.1016/j.advenzreg.2005.02.011
-
Samuel C E. 2001. Antivirus actions of interferon. Clin Microbiol Rev, 14 (4): 778-809.
doi: 10.1128/CMR.14.4.778-809.2001
-
Schanen C, Chieux V, Lobert P E, et al. 2006. Correlation between the anti-virus-induced cytopathic effect activity of interferon-alpha subtypes and induction of MxA protein in vitro. Microbiol Immunol, 50 (1): 19-24.
doi: 10.1111/mim.2006.50.issue-1